| 1 | JNJ | Johnson & Johnson | 7.39% |
| 2 | PFE | Pfizer Inc. | 7.36% |
| 3 | ABBV | AbbVie Inc. | 7.17% |
| 4 | MRK | Merck & Co., Inc. | 6.85% |
| 5 | BMY | Bristol-Myers Squibb Company | 6.28% |
| 6 | VTRS | Viatris Inc. | 3.96% |
| 7 | GILD | Gilead Sciences, Inc. | 3.78% |
| 8 | ZTS | Zoetis Inc. | 3.74% |
| 9 | AMGN | Amgen Inc. | 3.63% |
| 10 | BIIB | Biogen Inc. | 3.62% |
| 11 | UTHR | United Therapeutics Corporation | 3.56% |
| 12 | LLY | Eli Lilly and Company | 3.47% |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 3.00% |
| 14 | REGN | Regeneron Pharmaceuticals, Inc. | 2.99% |
| 15 | EXEL | Exelixis, Inc. | 2.36% |
| 16 | ELAN | Elanco Animal Health Incorporated | 2.35% |
| 17 | CRL | Charles River Laboratories International, Inc. | 2.11% |
| 18 | ILMN | Illumina, Inc. | 1.98% |
| 19 | OGN | Organon & Co. | 1.94% |
| 20 | MEDP | Medpace Holdings, Inc. | 1.87% |
| 21 | NBIX | Neurocrine Biosciences, Inc. | 1.61% |
| 22 | HALO | Halozyme Therapeutics, Inc. | 1.34% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.07% |
| 24 | ALKS | Alkermes plc | 1.03% |
| 25 | PRGO | Perrigo Company plc | 0.97% |
| View FTXH holdings |